We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Helmar Lehmann

Helmar C. Lehmann MD

Professor, Neurology, Centre of Neuromuscular Diseases, Department of Neurology, Medical Faculty, University of Cologne, Cologne, Germany

Helmar C. Lehmann, MD, is a professor of neurology and clinician-scientist at the Department of Neurology at the University of Cologne, Germany. He received clinical training at the Department of Neurology in Düsseldorf, Germany between 2003 and 2010. In 2004 and 2008-2009, Lehmann completed a postdoctoral research fellowship in the Neuromuscular Division, Department of Neurology, Johns Hopkins Hospital, Baltimore, USA. From 2010 to 2012 he worked as certified neurologist and consultant at the Department of Neurology in Düsseldorf.

Lehmann’s research is focused on pathogenesis and treatment of acquired peripheral nerve diseases. Specifically, he is interested in the pathogenesis of immune neuropathies including Guillain-Barré syndrome as well as toxic neuropathies. Other areas of research include the role of an aberrant immune response for injury of axons and Schwann cells in the peripheral and autonomic nervous system and mechanism of action of intravenous immunoglobulins and amyotrophic lateral sclerosis. Lehmann received research awards from the Peripheral Nerve Society, the Heinrich Heine University Düsseldorf and the German Association for Muscular Disorders. His research was funded by the German Research Foundation (DFG), the Else Kröner-Fresenius Foundation and the GBS/CIDP Foundation International.